Financial results - PHARMIMPEX SRL

Financial Summary - Pharmimpex Srl
Unique identification code: 1287055
Registration number: J52/341/1991
Nace: 5510
Sales - Ron
-
Net Profit - Ron
12.526
Employee
1
The most important financial indicators for the company Pharmimpex Srl - Unique Identification Number 1287055: sales in 2023 was - euro, registering a net profit of 12.526 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Hoteluri si alte facilitati de cazare similare having the NACE code 5510.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Pharmimpex Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 247.135 263.464 223.490 0 0 0 0 0 0 0
Total Income - EUR 247.308 263.672 377.552 3.147 7.932 80.722 0 0 0 108.062
Total Expenses - EUR 258.213 263.073 236.514 19.153 26.375 114.537 19.541 13.938 10.769 94.478
Gross Profit/Loss - EUR -10.905 598 141.038 -16.006 -18.443 -33.816 -19.541 -13.938 -10.768 13.585
Net Profit/Loss - EUR -10.905 598 118.983 -16.006 -18.443 -33.816 -19.541 -13.938 -10.768 12.526
Employees 6 5 3 3 2 2 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Pharmimpex Srl

Rating financiar

Financial Rating -
Pharmimpex Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Pharmimpex Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmimpex Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmimpex Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmimpex Srl - CUI 1287055

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 3.142 2.678 7.270 9.920 18.298 104.402 98.879 93.188 89.718 4.877
Current Assets 99.322 70.306 104.892 83.785 92.646 23.235 19.568 19.694 19.937 9.226
Inventories 47.572 38.918 53.747 57.971 84.863 8.539 5.486 5.364 5.381 3.823
Receivables 25.987 15.128 342 1.370 6.588 12.582 13.317 13.805 13.941 4.496
Cash 25.764 16.260 50.803 24.443 1.195 2.114 765 525 615 906
Shareholders Funds -8.795 -8.270 110.797 92.925 72.777 37.552 17.298 2.976 -7.783 4.767
Social Capital 91 92 91 99 97 95 93 91 91 91
Debts 111.665 81.396 1.365 780 38.167 90.085 101.148 109.906 117.437 9.337
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "5510 - 5510"
CAEN Financial Year 5510
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 9.226 euro in 2023 which includes Inventories of 3.823 euro, Receivables of 4.496 euro and cash availability of 906 euro.
The company's Equity was valued at 4.767 euro, while total Liabilities amounted to 9.337 euro. Equity increased by 12.526 euro, from -7.783 euro in 2022, to 4.767 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Pharmimpex Srl

Comments - Pharmimpex Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.